Departure or Appointment of Directors or Certain Officers
→
1/14/26
Agreement
Entry into a Material Definitive Agreement
→
12/29/25
Reg FD
Termination of a Material Definitive Agreement
→
12/23/25
Vote
Submission of Matters to a Vote of Security Holders
→
10/24/25
Other
Other Events
→
8/29/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
↓
Prospectuses & Registrations
40 shown
Filed
Form
Description
2/11/26
424B3
424B3
→
1/28/26
S-3
S-3
→
11/19/25
ARS
ARS
→
7/31/25
S-4/A
S-4/A
→
2/14/25
S-4
S-4
→
11/22/24
S-8
S-8
→
↓
Filing History(565 filings)
TypeDateAccessionPeriodSize
424B3
Feb 11, 2026
0001193125-26-045063424B3
—
205.4 KB
EFFECT
Feb 10, 2026
9999999995-26-000515
—
1.7 KB
8-K
Feb 6, 2026
0001193125-26-0411448-K
Feb 4, 2026
143.4 KB
S-3
Jan 28, 2026
0001193125-26-025262S-3
—
768.5 KB
D
Jan 27, 2026
0001469443-26-000001
—
12.2 KB
RW
Jan 20, 2026
0001193125-26-015604RW
—
16.4 KB
8-K
Jan 14, 2026
0001193125-26-0120288-K
Jan 9, 2026
751.8 KB
425
Dec 29, 2025
0001193125-25-335432425
—
78.6 KB
8-K
Dec 29, 2025
0001193125-25-3354108-K
Dec 24, 2025
215.7 KB
8-K
Dec 23, 2025
0001193125-25-3310098-K
Dec 19, 2025
175.9 KB
ARS
Nov 19, 2025
0001193125-25-288191ARS
Dec 31, 2024
1.3 MB
DEF 14A
Nov 19, 2025
0001193125-25-288164DEF 14A
Dec 19, 2025
2.9 MB
10-Q
Nov 7, 2025
0001193125-25-27237510-Q
Sep 30, 2025
11.3 MB
8-K
Nov 7, 2025
0001193125-25-2723688-K
Nov 7, 2025
792.2 KB
8-K
Oct 24, 2025
0001193125-25-2498548-K
Oct 22, 2025
190.1 KB
8-K
Aug 29, 2025
0000950170-25-1122678-K
Aug 26, 2025
161.0 KB
SCHEDULE 13G
Aug 19, 2025
0000950170-25-110227
—
6.9 KB
10-Q
Aug 14, 2025
0000950170-25-10904010-Q
Jun 30, 2025
11.2 MB
425
Aug 14, 2025
0000950170-25-108990425
—
593.7 KB
8-K
Aug 14, 2025
0000950170-25-1089838-K
Aug 14, 2025
727.6 KB
S-4/A
Jul 31, 2025
0000950170-25-100440S-4/A
—
34.6 MB
8-K
May 16, 2025
0000950170-25-0737118-K
May 14, 2025
170.1 KB
4
May 12, 2025
0000950170-25-0696334
May 9, 2025
5.3 KB
4
May 12, 2025
0000950170-25-0696264
May 9, 2025
5.3 KB
10-Q
May 8, 2025
0000950170-25-06642510-Q
Mar 31, 2025
10.3 MB
25 filings shown
Arcadia Biosciences, Inc. — SlamSEC
Proxies
27 shown
Filed
Form
Description
11/19/25
DEF 14A
DEF 14A
→
5/16/24
DEFA14A
DEFA14A
→
5/16/24
DEF 14A
DEF 14A
→
4/25/23
DEFA14A
DEFA14A
→
4/25/23
DEF 14A
DEF 14A
→
1/6/23
DEF 14A
DEF 14A
→
↓
Ownership
40 shown
Filed
Form
Description
5/12/25
4
4
→
5/12/25
4
4
→
2/5/25
4
4
→
2/5/25
4
4
→
8/21/24
4
4
→
8/21/24
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/10/26
EFFECT
EFFECT
→
1/27/26
D
D
→
1/20/26
RW
RW
→
12/29/25
425
425
→
8/19/25
SCHEDULE 13G
SCHEDULE 13G
→
8/14/25
425
425
→
↓
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.